Back to Treatments

Treatment

Gabapentin

4
Conditions
96
Trials
45K
Participants
63%
Average Safety

Condition Evidence

Fibromyalgia

10 trials · 3,000 participants

58% effectiveness · 58% safety

Menopause

6 trials · 4,000 participants

65% effectiveness · 65% safety

Peripheral Neuropathy

72 trials · 30K participants

75% effectiveness · 62% safety

Shingles

8 trials · 8,000 participants

70% effectiveness · 65% safety
Gabapentin | DFDA